Category: Emerging Infectious Diseases
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
(Fierce Biotech) Pfizer has had plenty of success in respiratory syncytial virus (RSV) lately, with multiple FDA designations and clinical advancements for its vaccine candidate. But that’s not enough for the pharma giant. Today, the New York-based behemoth is acquiring ReViral and its collection of therapeutics for the pesky respiratory virus for $525 million.
Nov 15, 2022
RSV antibody from Sanofi and AstraZeneca approved in Europe
(Chemical and Engineering News) With the first vaccines to guard against respiratory syncytial virus (RSV) expected to receive regulatory approval in the months ahead, the European Commission earlier this month gave its nod to a monoclonal antibody developed by Sanofi and AstraZeneca to prevent RSV lower respiratory tract illness (LRTI) in newborns and infants. The […]
Nov 15, 2022
RSV hospitalization rate for seniors is 10 times higher than usual for this point in the season
(CNN Video) The respiratory virus season has started early in kids this year and flooded children’s hospitals in many parts of the country – especially with respiratory syncytial virus, known as RSV. But adults can get RSV, too. Although RSV does not typically send as many adults to the hospital, it can be a serious and even deadly […]
Nov 15, 2022
RSV hospitalizations triple in recent weeks in Oregon
(Local News) Oregon Gov. Kate Brown issued an executive order Monday in response to the surge of pediatric cases and hospitalizations of respiratory viruses, including Respiratory Syncytial Virus. Cases of the virus, commonly known as RSV, have been rising across Oregon for the last four weeks. Brown said this executive order will give hospitals more […]
Nov 15, 2022
California child dies of flu and RSV as cases soar, hospitals threatened
(Los Angeles Times) Flu season has roared to life in California, reaching levels not seen in years and threatening to further strain a healthcare system already contending with an onslaught of RSV cases and still-potent circulation of the coronavirus. Underscoring the worrisome conditions, California Department of Public Health officials on Monday reported the season’s first death of […]
Nov 15, 2022
Can mRNA vaccines transform the fight against Ebola?
(Nature) COVID-19 vaccines that rely on mRNA technology are credited with transforming humanity’s fight against the coronavirus pandemic. The vaccines — one made by drug giant Pfizer with German biotech firm BioNTech, another by US pharmaceutical company Moderna — sped through clinical trials in just months and gained approval from major regulatory bodies less than a year after […]
Nov 14, 2022
First Ebola death confirmed in Jinja
(Monitor) The 45-year-old, Dan Waiswa, a farmer and resident of Kayalwe B village, in the Buyengo Town Council, Jinja District was admitted at Buwenge Health Center IV following his referral from a private clinic in Buwenge town council early this week
Nov 14, 2022
Uganda confirms Ebola case in country’s east as outbreak expands
(Reuters) An Ebola case has been confirmed in Jinja in eastern Uganda, the country’s health minister said on Sunday, the first time the outbreak has spread to a new region of the country from central Uganda where cases have been confined so far. Authorities have been struggling to contain the highly infectious and deadly haemorrhagic […]
Nov 14, 2022
‘I Didn’t Think COVID-19 Was Real’: Why 40% Misled During the Pandemic
(MedPageToday) Two in five Americans say they either misled others about their COVID-19 infection or vaccination status, or didn’t follow pandemic-related public health measures, a new study indicated. In a survey involving over 1,700 respondents, 41.6% suggested they either misrepresented and/or did not adhere to at least one of nine survey items, most commonly 24.3% […]
Nov 11, 2022
(Lancet) Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants. The burden of RSV infection in healthy term infants has not yet been established. Accurate health-care burden data in healthy infants are necessary to determine RSV immunisation policy when RSV immunisation becomes available.
Nov 11, 2022